This is just crazy news for BD1. With 80m shares on issue, $1.30 is only a touch over $100m. They should be many multiples of this. 100% specificity and sensitivity in all stages of ovarian cancer?? Come one.... this is good damn huge. Worldwide rights?
Let this filter into the investing community and it will crack $10 in time (no not tomorrow).
Ann: Outstanding SubB2M Ovarian Cancer Test Data, page-114
-
- There are more pages in this discussion • 419 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
-0.010(2.22%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 44.0¢ | 43.0¢ | $7.597K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21334 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 8500 | 1 |
View Market Depth
| Last trade - 12.25pm 13/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |